Your browser doesn't support javascript.
Initial experience of the safety and tolerability of the BNT162b2 (Pfizer-Bio-N-Tech) vaccine in extremely vulnerable children aged 12-15 years.
King, Hayley; Deshpande, Sanjay; Woodbridge, Tamsin; Hilliard, Tom; Standing, Jon; Lewis, Mary; Ward, Lesley; Finn, Adam; Roderick, Marion.
  • King H; Department of Paediatric Immunology and Infectious Diseases, Bristol Royal Hospital for Children, Bristol, UK.
  • Deshpande S; Department of Paediatric Immunology and Infectious Diseases, Bristol Royal Hospital for Children, Bristol, UK.
  • Woodbridge T; Community Paediatrics, Southmead House, Sirona Care and Health CIC, Kingswood, South Gloucestershire, UK.
  • Hilliard T; Department of Respiratory Medicine, Bristol Royal Hospital for Children, Bristol, UK.
  • Standing J; Department of Pharmacy, Bristol Royal Hospital for Children, Bristol, UK.
  • Lewis M; Immunisation, Sirona Care and Health CIC, South Gloucestershire, UK.
  • Ward L; William Budd Health Centre, Knowle West Health Park, Swift pcn, Bristol, UK.
  • Finn A; Department of Paediatric Immunology and Infectious Diseases, Bristol Royal Hospital for Children, Bristol, UK.
  • Roderick M; Population Health Sciences, University of Bristol, Bristol, Bristol, UK.
Arch Dis Child ; 107(2): 205-207, 2022 02.
Article in English | MEDLINE | ID: covidwho-1375293

Full text: Available Collection: International databases Database: MEDLINE Main subject: Vaccination / Fever / Injection Site Reaction / COVID-19 / BNT162 Vaccine Type of study: Diagnostic study / Observational study / Prognostic study Topics: Vaccines Limits: Adolescent / Adult / Child / Humans / Middle aged / Young adult Language: English Journal: Arch Dis Child Year: 2022 Document Type: Article Affiliation country: Archdischild-2021-322655

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Vaccination / Fever / Injection Site Reaction / COVID-19 / BNT162 Vaccine Type of study: Diagnostic study / Observational study / Prognostic study Topics: Vaccines Limits: Adolescent / Adult / Child / Humans / Middle aged / Young adult Language: English Journal: Arch Dis Child Year: 2022 Document Type: Article Affiliation country: Archdischild-2021-322655